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Abstract
The pathology of Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-b (Ab) peptide, hyperpho-
sphorylated tau protein, neuronal death, and synaptic loss. By means of long-term two-photon in vivo imaging and confocal
imaging, we characterized the spatio-temporal pattern of dendritic spine loss for the first time in 3xTg-AD mice. These mice
exhibit an early loss of layer III neurons at 4 months of age, at a time when only soluble Ab is abundant. Later on, dendritic
spines are lost around amyloid plaques once they appear at 13 months of age. At the same age, we observed spine loss also
in areas apart from amyloid plaques. This plaque independent spine loss manifests exclusively at dystrophic dendrites that
accumulate both soluble Ab and hyperphosphorylated tau intracellularly. Collectively, our data shows that three spatio-
temporally independent events contribute to a net loss of dendritic spines. These events coincided either with the
occurrence of intracellular soluble or extracellular fibrillar Ab alone, or the combination of intracellular soluble Ab and
hyperphosphorylated tau.
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Introduction
Alzheimer’s disease (AD) is the most common age-related
neurodegenerative disorder. Pathognomonic features include the
accumulation of amyloid-b (Ab) peptide, hyperphosphorylated tau
protein, neuronal death, and synaptic loss [1,2]. AD is clinically
characterized by a gradual and global decline of cognitive function.
Synaptic loss as one of the hallmarks of AD is the best correlate of
cognitive decline and has previously been detected in the human
cortex and hippocampus [1,3–9]. This suggests that synaptic loss
represents a critical event in the pathophysiology of AD.
It is widely believed that the abundance of Ab plays a central
role in the pathogenesis of AD. However, which Ab species, i.e.
soluble forms like monomers and oligomers or insoluble fibrils
primarily contributes to AD pathogenesis and in what way
remains controversial [10,11]. Indeed, the abundance of soluble
Ab levels in the cortex correlates positively with the first cognitive
deficits and synaptic loss [12,13] long before fibrillar Ab plaques
accumulate [1,14]. This has been modeled in AD transgenic mice
that exhibit early synaptic loss and cognitive decline at a time,
when only soluble Ab is present, but before amyloid plaques
become abundant [15–20]. Moreover, several in vitro studies have
convincingly demonstrated that high levels of soluble Ab directly
lead to synaptic loss [21–25]. In addition to soluble Ab, there is
also evidence from transgenic AD mouse models that synaptic loss
occurs in close proximity to insoluble fibrillar Ab plaque deposits
[26–31]. Besides the accumulation of soluble and insoluble Ab, the
intraneuronal abundance of hyperphosphorylated filamentous tau
protein represents the second major pathological signature of AD
[32–34], which correlates well with cognitive impairment [35,36].
Collectively, it is of great significance to understand how soluble
Ab, insoluble amyloid plaques and hyperphosphorylated tau
accumulation contribute to synaptic loss in AD.
We monitored dendritic spines by long-term two-photon in vivo
imaging in AD transgenic mice that were crossed with YFP-H
mice expressing yellow fluorescent protein (YFP) in a subset of
cortical neurons [37]. Long-term two-photon in vivo imaging
provides a powerful tool to explore structural plasticity at the level
of individual spines and neurons followed over extended time
periods in living mice [38–45]. Specifically, dendritic spines of
apical dendrites of layer III and layer V neurons in the
somatosensory cortex were repeatedly analyzed. Dendritic spines
embody the post-synaptic side of excitatory synapses and are as
such a reliable indicator of synapses themselves. They are also
highly plastic structures and represent a structural correlate of
learning and memory processes in the mammalian brain [46–48].
The aim of our study was to analyze structural plasticity of
dendritic spines in triple transgenic AD mice (3xTg-AD) which
progressively develop both Ab and tau pathology in the cortex
and hippocampus [49]. This leads to a distinct spatio-temporal
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pattern of dendritic spine loss which we characterize here for the
first time.
Materials and Methods
Transgenic mice
Homozygous triple transgenic mice (3xTg-AD) [49] were crossed
with heterozygous mice of the YFP-H line [37] (The Jackson
Laboratory, Bar Harbor, USA). The offspring was crossed back
with homozygous 3xTg-AD mice to yield quadruple transgenic
animals homozygous for the knock-in mutation and the AD
transgenes and heterozygous for YFP-H. As controls, age-matched
heterozygous YFP-H mice on the same background were used.
Mice were of mixed gender. All procedures were in accordance with
an animal protocol approved by the University of Munich and the
government of upper Bavaria (Az. 55.2-1.54-2531-110-06).
Cranial window surgery
A cranial window over the right cortical hemisphere was
surgically implanted as previously described [43,45]. Imaging
began following a 21 day rest period after surgery.
Long-term two-photon in vivo imaging
Long-term two-photon imaging was performed as previously
described [43,45]. Less than 50 mW laser power was used to avoid
laser-induced phototoxicity. For overview images z-stacks of
150 mm depth with 2 mm z-resolution and 102461024 pixels per
image frame (0.22 mm/pixel) were taken with a Zeiss 40x water
immersion objective (0.8 NA) to count dystrophic dendrites. In
order to count dendritic spines, higher resolution images were
taken with the same objective with 1 mm z-resolution and
5126512 pixels per image frame (0.11 mm/pixel). To follow the
fate of individual cortical layer III neurons a Zeiss 20x water-
immersion objective (1.0 NA) was used to acquire image stacks of
300 mm depth with 3 mm z-resolution and 102461024 pixels per
image frame (0.41 mm/pixel).
Immunohistochemistry
An immunohistochemical staining protocol was adapted from
Gogolla et al. [50]: Following transcardial perfusion with 4%
paraformaldehyde 100 mm thick free-floating sections were
prepared. The following antibodies conjugated to biotin were
used in 1:100 dilutions: 6E10 mAb (Covance Research Products
Inc., Denver, PN, USA), anti-Ab-oligomer A11 (Invitrogen,
Carlsbad, CA, USA), anti-human Tau clone HT7 mAb and
anti-PHF-Tau clone AT8 mAb (Thermo Scientific Pierce Protein
Research Products, Rockford, IL, USA). Secondary detection was
performed with the TSATM kit #26 with streptavidin-HRP
(Invitrogen, Carlsbad, CA, USA). Alexa Fluor 647 tyramide was
incubated for 3 hours. Staining of fibrillar Ab plaques and
neurofibrillary tangles was performed with 145 mM methoxy-
X04 in PBS for 30 min and subsequently washed with PBS.
Fluorescence images were acquired with a confocal laser scanning
microscope mounted on an inverted microscope support (LSM
510 and AxioVert 200, Carl Zeiss MicroImaging GmbH, Jena,
Germany). Two different immersion oil objectives were used, a 25x
(LD LCI Plan-Apochromat NA 0.8) and a 40x (Plan-Apochromat
NA 1.3) (Carl Zeiss MicroImaging GmbH, Jena, Germany). XYZ-
spacing was 0.1860.1861 mm3 and 0.1160.1161 mm3, respectively.
DAPI and Nissl staining
This was previously described [45]. Briefly, brains were fixed
with 4% PFA in PBS at 4uC overnight. DAPI and Nissl staining
was performed on 100 mm thick fixed brain slices that were cut in
the same orientation as the in vivo images were taken. Free-floating
sections were permeabilized with 2% Triton X-100 overnight.
DAPI (10 mg/ml) and Nissl (20x dilution in PBS; # N-21482;
Molecular Probes/Invitrogen, Carlsbad, CA, USA) was adminis-
trated and incubated for 2 hours and rinsed with PBS three times
for 10 minutes. Fluorescence images were acquired with a confocal
laser scanning microscope mounted on an inverted microscope
support (LSM 510 and AxioVert 200, Carl Zeiss MicroImaging
GmbH, Jena, Germany). Three different lasers were used for
excitation: Ar ion laser at 514 nm for YFP, HeNe laser at 543 nm
for Nissl, and a Ti-Sapphire laser (Mai Tai DeepSee, Spectra-
Physics Lasers Division, Newport Corporation, Mountain View,
CA, USA) at 780 nm for DAPI. A 25x (LD LCI Plan-Apochromat
NA 0.8) immersion oil objective was used (Carl Zeiss MicroImaging
GmbH, Jena, Germany). XYZ-spacing was 0.3660.3662 mm3.
Image processing and data analysis
All images were deconvolved using the adaptive blind 3D
deconvolution algorithm of AutoDeblur with 10 iterations
(Version x2.0.1, Media Cybernetics Inc., Bethesda, MD, USA).
The images were maximum intensity projected (Imaris 6.1,
Bitplane, Zu¨rich, Switzerland). In some figures, distracting
neighboring dendritic elements were removed. The volume of
dystrophic dendrites was automatically calculated using Imaris
software (Version 6.1, Bitplane, Zu¨rich, Switzerland). In this case
dendrites were classified as dystrophic if they exhibited at least a 2-
fold increased dendritic volume over the whole imaging period.
Spines were counted in z-stacks by manually scrolling through the
images of subsequent time points of the same position. The spine
scoring method has previously described [42,43,51]. Spine
densities refer to the amount of spines per dendrite length in mm
from which they protrude. Spines lasting for less than 8 days were
classified as transient and spines with a lifetime of 8 days or more
as persistent [41,52]. All results are reported as mean 6SEM.
Statistical differences in measurements over time were determined
using repeated measures ANOVA while statistical comparison
between groups was performed with the Wilcoxon Rank Sum Test
or the Student’s t-test as indicated. The Pearson product-moment
correlation coefficient R was calculated to determine a correlation
between dendritic volume and dendritic spine density.
Results
The 3xTg-AD mouse line harbors a knock-in mutation for
presenilin 1 (PS1M146V) and transgenes for the amyloid precursor
protein (APPswe) and for tau (tauP301L) and progressively develops
both an Ab and tau pathology in the cortex and hippocampus
[49]. Soluble Ab can already be detected at 4 months of age in the
hippocampus and cortex (Fig. S1A), but fibrillar amyloid plaques
do not appear before 12 months of age (Fig. S1B). Once they form,
amyloid plaques are present in the hippocampus and in the frontal
cortex, while the somatosensory cortex is free of plaques, even at
20 months of age (Fig. S1B). Hyperphosphorylated tau is abundant
in the hippocampus and cortex from 12 months on (Fig. S1C).
Dendritic spine loss in the hippocampus
Based on this spatio-temporal pattern of Ab and tau pathology,
dendritic spine density was analyzed in the hippocampus and
frontal cortex of 6, 10, 15, and 20 month old mice by confocal
imaging in fixed slices (Fig. 1). In total, 21,220 spines were counted
on 50 dendrites per group (n= 5 mice per group). Hereby, we
detected no difference in dendritic spine density between 3xTg-
AD mice and controls at 6 and 10 months of age. This age is prior
to the appearance of amyloid plaques and hyperphosphorylated
Dendritic Spine Loss in 3xTg-AD Mice
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tau (Fig. S1B and S1C). In 15 months old 3xTg-AD mice, once
amyloid plaques and hyperphosphorylated tau are abundant, the
dendritic spine density was significantly reduced not only around
amyloid plaques (d,50 mm) (Fig. 1A, 1C, and 1D; hippocampus:
0.8060.02 mm21 vs. 1.0160.03 mm21, P,0.001; frontal cortex:
0.4660.01 mm21 vs. 0.5460.02 mm21, p,0.001) but also in areas
distant to plaques (d.50 mm) compared to controls (Fig. 1B, 1C,
and 1D; hippocampus: 0.8960.02 mm21 vs. 1.0160.03 mm21,
p,0.01; frontal cortex: 0.5160.01 mm21 vs. 0.5460.02 mm21,
P,0.05). The dendritic spine density further decreased from 15 to
20 months while it remained unchanged in age-matched wild type
control mice (Fig. 1C and 1D). The threshold of 50 mm was used
since previous studies in different AD mouse models have shown
that the dendritic spine density is predominantly reduced within a
radial distance of 50 mm around amyloid plaques [26–28]. In
conclusion, spine loss in the hippocampus was not only apparent
in proximity to amyloid plaques. It also occurred in areas distant
from plaques.
Dendritic spine loss in the somatosensory cortex
To analyze dendritic spine loss in the absence of amyloid
plaques in more detail, we monitored dendritic spines in the
somatosensory cortex where no amyloid plaques are present at any
age (Fig. S1B). By long-term two-photon in vivo imaging (Fig. 2A–
C), the fate of individual dendritic spines was analyzed in four age
groups (4–6, 8–10, 13–15, and 18–20 months) in 3xTg-AD mice
and age-matched non-AD transgenic control mice (n = 4 mice per
group) for up to 60 days (in total n = 100,642 spines).
Dendritic spine density did not change over time (Fig. 2D1, 2D2,
2E1, 2E2) in 4–6 and 8–10 months-old 3xTg-AD mice, when only
soluble Ab, but neither hyperphosphorylated tau nor amyloid
plaques are present in the somatosensory cortex (Fig. S1). In these
age groups, dendritic spine density remained at a level comparable
to age-matched wild type controls (Fig. 2D1, 2D2, 2E1, 2E2). At 13-
15 months of age, when both soluble Ab and hyperphosphorylated
tau accumulate in the somatosensory cortex (Fig. S1), dendritic
spine density significantly decreased over time by 1.8460.84
spines day21 mm21 (Fig. 2D3, 2E3; 0.4260.04 mm
21 to
0.3660.02 mm21, P,0.001). The decline was even stronger in
18–20 month-old 3xTg-AD mice and progressed with 4.2560.79
spines day21 mm21 (Fig. 2D4, 2E4; 0.3660.03 mm
21 to
0.2760.01 mm21, P,0.001). At 13–15 and 18–20 months of
age, the spine density of wild type mice did not decrease over time
(Fig. 2D3, 2D4, 2E3, 2E4).
In addition to dendritic spine density, the experimental design
enabled us to analyze the fate of functional synapses over time.
Dendritic spines with a lifetime of more than eight days were
classified as ‘‘persistent’’ spines (Fig. 2B and 2C). It has been
shown that the majority of persistent spines predominantly forms
functional synapses with presynaptic boutons [52]. In contrast,
short-lived ‘‘transient’’ dendritic spines, with a lifetime of less than
eight days, primarily represent non-functional synapses
[39,44,51,52]. Between 4–6 and 8–10 months of age, when the
spine density remained constant, neither the persistent nor the
transient spine density was altered (Fig. 2F1, 2F2, 2G1, 2G2). This
changed at 13–15 months, when specifically persistent spines were
lost (Fig. 2F3). Interestingly, the density of transient spines was
significantly increased during this time-period, compensating at
least partially for the loss of persistent spines (Fig. 2G3;
0.02860.009 mm21 to 0.01560.007 mm21, P,0.001). This com-
pensatory increase in the density of transient spines was not
apparent at 18–20 months (Fig. 2G4), resulting in an even more
pronounced loss of spines at this age (Fig. 2E4).
Dendritic dystrophy coincides with dendritic spine loss in
the somatosensory cortex
At the same time when we observed a decline in dendritic spine
density in the somatosensory cortex of 13–15 and 18–20 months-
old 3xTg-AD mice, we noticed that some dendrites showed a
dystrophic volume increase over time (Fig. 3A and 3B). Figures 3A
and 3B exemplarily illustrate a dendrite that became dystrophic
and lost spines over 60 days compared to a neighboring dendrite
that neither exhibited dystrophic swellings nor spine loss (see also
Video S1). The analysis of spines at dystrophic and non-dystrophic
dendrites revealed that dystrophic dendrites showed a significant
decline in spine density over time (Fig. 3C; 0.4060.03 mm21 to
0.2660.04 mm21, P,0.001). Dendrites of wild type control mice
displayed unchanged spine densities and dystrophic changes were
never observed (Fig. 3C). Interestingly, the volume of dystrophic
dendrites did not stay at a constant level over time, but
significantly increased (P,0.001), indicating a progressing pathol-
ogy (Fig. 3D). Moreover, a strong correlation was identified
between a reduction of dendritic spine density and an increase in
dendritic volume (Fig. 3E; R2= 0.84, P,0.001). Additionally, as
shown above, the spine density was unaffected before the first
dystrophies emerged at 13 months (Fig. 2E1 and 2E2). From that
age on, the number of dystrophies significantly increased from
9.5863.056103 mm23 at 15 months to 33.2367.026103 mm23
at 20 months (Fig. 3F; P = 0.004), indicating a progression with
age.
In order to clarify if soluble Ab and tau were present in
dystrophic dendrites, we performed immunohistochemistry with
antibodies 6E10, A11, HT7, and AT8 on fixed slices (Fig. 3G).
Indeed, soluble Ab and hyperphosphorylated tau protein were
abundant in all analyzed dystrophic dendrites (n = 2,305 dystro-
phies in n= 13 mice). This strongly indicates a relationship
between intracellular Ab and hyperphosphorylated tau accumu-
lation on one side and spine loss at dystrophic dendrites on the
other.
We can exclude the possibility that dendritic dystrophy was
caused by cranial window surgery and laser-induced phototoxicity,
since neighboring dendrites that were imaged with the identical
parameters did not exhibit any dystrophic changes (Fig. 3A and 3B
and Video S1). In addition, dystrophic dendrites were also
apparent in cortical slices of 3xTg-AD mice that underwent
neither cranial window surgery, nor two-photon in vivo imaging
(Fig. 3G and 3H).
Early layer III neuron loss in the somatosensory cortex
While we analyzed dendritic spines on apical dendrites of layer
III and layer V cortical neurons in 3xTg-AD mice, we occasionally
observed dendrites disappearing from one imaging time point to
the next (Fig. 4A). When we followed the disappearing dendrite to
the corresponding layer III neuron in previous images, we realized
that the neuron had in fact disappeared along with the dendrite
(Fig. 4A). Neighboring neurons and dendrites persisted over the
entire imaging period (Fig. 4A), whereas the disappeared neurons
and dendrites did not reappear in subsequent imaging sessions.
Based on these observations, layer III neuron loss was
systematically analyzed by two-photon in vivo imaging stereology
as previously described [45]. Therefore, identical YFP expressing
layer III neurons were imaged and counted at day 0 and 30 days
later in 3xTg-AD and non-transgenic mice. Neuron loss
manifested only in 3xTg-AD mice, whereas not a single neuron
loss was detected in non-AD transgenic control mice (Fig. 4B;
decrease of 4.661.1% vs. 0.060.0% respectively; P= 0.012,
Student’s t-test; n = 1,200 neurons imaged in a total volume of
2.22 mm3 in n= 18 mice). Layer III neuron loss was apparent at
Dendritic Spine Loss in 3xTg-AD Mice
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Figure 1. Dendritic spine density is reduced in the hippocampus and frontal cortex from 15 months on. (A, B) High-resolution images of
dendrites and dendritic spines in the vicinity of (d,50 mm) and distant to (d.50 mm) amyloid plaques in the hippocampus. Scale bars: 10 mm
(overviews); 2 mm (close ups) (C, D) In the hippocampus (C) and frontal cortex (D) of 15 and 20 month-old 3xTg-AD mice, the dendritic spine density
was significantly reduced in areas close to (grey columns) and distant from (black columns) amyloid plaques compared to non-AD transgenic control
mice (white) (* P,0.05, ** P,0.01, *** P,0.001, Student’s t-test, n = 50 dendrites in n= 5 mice per group). The dendritic spine density was unchanged
at 6 and 10 months of age. Error bars indicate +S.E.M.
doi:10.1371/journal.pone.0015477.g001
Dendritic Spine Loss in 3xTg-AD Mice
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4–6 months of age when oligomeric Ab accumulates in 3xTg-AD
mice [53].
Importantly, before dendrites disappeared due to neuron loss
their spine density was comparable to the spine density of
dendrites that persisted (Fig. 4C; 0.4060.01 mm21 vs.
0.4360.02 mm21 respectively; n = 10 dendrites per group). This
indicates that the dendritic spine density was not altered before the
neuron was lost and therefore spine loss did not precede layer III
neuron loss. Obviously, when a neuron was lost all dendrites and
spines that protruded from this neuron were lost, too.
To determine if the disappearance of neurons was based on a
loss of YFP expression or if the neuron itself was lost, we
performed post-mortem nuclear DAPI- and neuronal Nissl-
staining of the same area where neuron loss has previously been
detected by two-photon in vivo imaging. This experimental
approach has previously been described in detail [45]. As
expected, the lost neurons were not labeled positive for DAPI or
Nissl compared to neighboring neurons that were still present
(Fig. 4D). This provides strong evidence, that these neurons were
in fact lost and did not just loose YFP expression.
Discussion
It has previously been shown that Ab oligomer administration
[23,24] and virally induced overexpression of mutated APP
[22,25] led to a reduced dendritic spine density in hippocampal
slice cultures. Further evidence from AD mouse models shows that
a decline in the density of the synaptic marker synaptophysin and
Figure 2. Dendritic spine density progressively declines in the somatosensory cortex from 13 months on. (A) A cranial window was
implanted over the somatosensory cortex to perform long-term two-photon in vivo imaging of neurons, dendrites, and dendritic spines. (B) High-
resolution time-lapse images of a dendritic region (blue box in A) over 16 days. Present spines (blue arrows), lost spines (red arrows), and gained
spines (green arrows) are exemplarily marked. (C) Classification of the 5 spines marked in B in categories of persistent (lifetime$8 days) and transient
spines (lifetime,8 days). (D) Start and end point images of a 49-60 day in vivo imaging period of dendrites and dendritic spines in the somatosensory
cortex of 4–6 (D1), 8–10 (D2), 13–15 (D3), and 18–20 (D4) months old 3xTg-AD mice. Color code of arrows as in B. (E–G) Dendritic spines imaged in 4–6
(1), 8–10 (2), 13–15 (3), and 18–20 (4) months old 3xTg-AD mice and age-matched non-AD transgenic control mice over a 49–60 day in vivo imaging
period. (E) Dendritic spine density, (F) density of persistent dendritic spines, (G) density of transient dendritic spines. Each circle indicates one imaging
time point 6S.E.M. (*** P,0.001, repeated measures ANOVA (E and F) or Wilcoxon Rank Sum Test (G), n = 4 mice per group). Scale bars: 20 mm (A),
2 mm (B and D);
doi:10.1371/journal.pone.0015477.g002
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in dendritic spine density have also been detected at a time, when
only soluble Ab but no amyloid plaques were present [15–18].
Our working hypothesis was to determine if this early decline in
dendritic spine density is also apparent in 3xTg-AD mice [49]
where cognitive decline [54] and accumulation of oligomeric Ab
[53] occurs as early as 4–6 months of age before amyloid plaques
and hyperphosphorylated tau are present. To our surprise, at
those early stages, loss of dendritic spines was only observed as a
consequence of layer III neuron loss. This indicates that soluble
Ab, which accumulates at this age [45,53], is toxic at least for a
Figure 3. Dendritic spine density is reduced exclusively at dystrophic, soluble Ab and hyperphosphorylated tau accumulating
dendrites. (A, B) Time-lapse images of dystrophic and non-dystrophic dendrites over 60 days. Dendritic dystrophies (yellow circles), stable (blue
arrows), lost (red arrows), and gained dendritic spines (green arrows) at corresponding time-points are labeled. (C, D) Changes in dendritic spine
density (C) and dendritic volume (D) over 60 days at dystrophic, non-dystrophic and control dendrites in 13–20 month-old mice. Note that the
dendritic spine density of dystrophic dendrites significantly decreased over time, while the mean dendritic volume of the same dendrites significantly
increased (*** P,0.001, repeated measures ANOVA, n = 4 mice per group). Each circle represents one imaging time-point. (E) In 3xTg-AD mice, the
dendritic volume and spine density are inversely correlated (R2 = 0.84, P,0.001, n = 4 mice), indicating a relationship between both events. (F) The
mean number of dystrophic dendrites per volume significantly increased from 15 to 20 months of age (** P,0.01, Student’s t-test, n = 8–10 mice per
age group). (G) Dendritic dystrophies in the somatosensory cortex were labeled positive for antibodies 6E10, A11, HT7, and AT8 via
immunofluorescence staining. Co-localization (yellow) of each antibody (red) and YFP (green) in merged images. (H) Cortical section of a 20 month-
old 3xTg-AD mouse expressing YFP in cortical neurons that has not previously been imaged in vivo. Dystrophic dendrites (white arrows) are abundant
in cortical layers 1–3. Error bars: 6S.E.M. Scale bars: 10 mm (A, G, H) 2 mm (B),
doi:10.1371/journal.pone.0015477.g003
Figure 4. Early layer III neuron loss leads to spine loss. (A) Two-photon in vivo images of the identical cortical region of a 4 months old 3xTg-
AD mouse showing a selective disappearance of an apical dendrite in layer 1–2 (red arrows) and the corresponding layer III neuron after 3 days, while
a neighboring dendrite and neuron persisted (blue arrows). Scale bars: 20 mm. (B) Neuron loss in a 30 day interval was exclusively detected in 3xTg-
AD mice compared to control mice (* P,0.05, Student’s t-test, n = 1,200 neurons). Error bars indicate +S.E.M. (C) Mean dendritic spine density of
disappearing dendrites remained unchanged before the loss of the neuron. Dendritic spine density remained at a level comparable to the spine
density of persistent dendrites of the same 4–6 months old 3xTg-AD mice and controls (n = 10 dendrites per group). Error bars indicate 6S.E.M. (D)
Two-photon in vivo images of the same layer III neurons in a 4 months old 3xTg-AD mouse and 30 days later. A single neuron disappeared after 30
days (red circle) while a neighboring YFP positive neuron persisted (blue circle). After the neuron loss occurred, the brain was paraformaldehyde
fixed, cut in 100 mm thick sections, and the nuclei were labeled with DAPI while neurons were selectively labeled with Nissl-Red. Neither DAPI, nor
Nissl staining was detected at the position where neuron loss was previously detected in the in vivo image (red circle) while the persisting neuron was
labeled with DAPI and Nissl (blue circle). Scale bars: 20 mm.
doi:10.1371/journal.pone.0015477.g004
Dendritic Spine Loss in 3xTg-AD Mice
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15477
subset of cortical neurons. Most importantly, in 3xTg-AD mice we
did not find any evidence that soluble Ab leads to dendritic spine
loss at intact dendrites as anticipated by previous studies
[16,17,21–25]. How can this discrepancy be explained? One
possibility is that in 3xTg-AD mice the soluble Ab concentrations
at dendritic spines are significantly lower than the concentrations
that led to dendritic spine loss in the previous in vitro studies [21–
25]. In addition, the spatio-temporal distribution of soluble Ab
might be different in 3xTg-AD compared to other AD mouse
models that show an early decline in spine density [16,17].
In 3xTg-AD mice, a decline in the density of dendritic spines of
individual dendrites could first be observed at the age of 13
months. Hereby, the dendritic spine density was reduced in close
proximity to amyloid plaques. This finding is in line with
observations from other mouse models [26–31]. In addition,
3xTg-AD mice show a strong decline in spine density also distant
to amyloid plaques. Interestingly, spine density was exclusively
reduced at dystrophic dendrites, where both oligomeric Ab and
hyperphosphorylated tau were intracellularly abundant.
Collectively, three spatio-temporally independent events lead to
a net loss of dendritic spines in 3xTg-AD mice. First, layer III
neuron loss occurs early at the time when soluble Ab accumulates.
Consequently, dendritic spines of these neurons get lost. Second,
from 13 months on, at a time when amyloid plaques are abundant,
the dendritic spine density declines in proximity to amyloid
plaques. Third, starting at 13 months, a reduction in dendritic
spine density manifests also in areas apart from amyloid plaques.
This plaque independent spine loss occurs exclusively at
dystrophic dendrites that accumulate both Ab oligomers and
hyperphosphorylated tau intracellularly. Taken together, we
identified three independent events that contribute to a loss of
dendritic spines in 3xTg-AD. Each of these events can individually
lead to dendritic spine loss. This implies that AD therapies which
are only directed at one of these causes probably fall short to
counteract the full spectrum of dendritic spine loss in AD.
Supporting Information
Figure S1 Ab and tau pathology in 3xTg-AD mice. (A-C)
Immunofluorescence images of hippocampal and cortical slices of
6, 10, 15, and 20 month-old 3xTg-AD mice stained with 6E10
antibody (A), methoxy-X04 which labels fibrillar aggregates like
Ab plaques (arrows) or neurofibrillary tangles (B). AT8 antibody
binds to hyperphosphorylated tau (C). Scale bars: 20 mm
(hippocampus) 50 mm (cortex) (TIF)
Video S1 Dendritic dystrophy in 3xTg-AD mice. In 13
months old 3xTg-AD mice, some dendrites started to become
dystrophic while neighboring dendrites showed a normal volume
over the whole imaging period of 60 days. Scale bar: 10 mm (AVI)
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